{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:46:51Z","timestamp":1793969211251,"version":"4.8.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41589-020-00708-z","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T12:40:31Z","timestamp":1610368831000},"page":"237-245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Hierarchical chemical determination of amyloid polymorphs in neurodegenerative disease"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1609-1539","authenticated-orcid":false,"given":"Dan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3425-6672","authenticated-orcid":false,"given":"Cong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"708_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"VM Lee","year":"2001","unstructured":"Lee, V. M., Goedert, M. & Trojanowski, J. Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121\u20131159 (2001).","journal-title":"Annu. Rev. Neurosci."},{"key":"708_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn1007","volume":"4","author":"C Soto","year":"2003","unstructured":"Soto, C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 49\u201360 (2003).","journal-title":"Nat. Rev. Neurosci."},{"key":"708_CR3","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin, M. T. & Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787\u2013795 (2006).","journal-title":"Nature"},{"key":"708_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"708_CR5","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin, D. J., Lee, V. M. & Trojanowski, J. Q. Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies. Nat. Rev. Neurosci. 14, 626\u2013636 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"708_CR6","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","volume":"348","author":"RL Nussbaum","year":"2003","unstructured":"Nussbaum, R. L. & Ellis, C. E. Alzheimer\u2019s disease and Parkinson\u2019s disease. N. Engl. J. Med. 348, 1356\u20131364 (2003).","journal-title":"N. Engl. J. Med."},{"key":"708_CR7","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science 276, 2045\u20132047 (1997).","journal-title":"Science"},{"key":"708_CR8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1212\/WNL.45.3.555","volume":"45","author":"R Mayeux","year":"1995","unstructured":"Mayeux, R. et al. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer\u2019s disease. Neurology 45, 555\u2013557 (1995).","journal-title":"Neurology"},{"key":"708_CR9","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.neuron.2018.11.043","volume":"100","author":"WA Eimer","year":"2018","unstructured":"Eimer, W. A. et al. Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 100, 1527\u20131532 (2018).","journal-title":"Neuron"},{"key":"708_CR10","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167, 1469\u20131480.e12 (2016).","journal-title":"Cell"},{"key":"708_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-020-2043-0","volume":"580","author":"W Zhang","year":"2020","unstructured":"Zhang, W. et al. Novel tau filament fold in corticobasal degeneration. Nature 580, 283\u2013287 (2020).","journal-title":"Nature"},{"key":"708_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser, M. et al. Structures of \u03b1-synuclein filaments from multiple system atrophy. Nature 585, 464\u2013469 (2020). This study reports the pathological fibril structure of \u03b1-synuclein derived from patients of multiple system atrophy.","journal-title":"Nature"},{"key":"708_CR13","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","volume":"148","author":"D Eisenberg","year":"2012","unstructured":"Eisenberg, D. & Jucker, M. The amyloid state of proteins in human diseases. Cell 148, 1188\u20131203 (2012).","journal-title":"Cell"},{"key":"708_CR14","doi-asserted-by":"publisher","first-page":"eaat8407","DOI":"10.1126\/science.aat8407","volume":"362","author":"TI Kam","year":"2018","unstructured":"Kam, T. I. et al. Poly(ADP-ribose) drives pathologic \u03b1-synuclein neurodegeneration in Parkinson\u2019s disease. Science 362, eaat8407 (2018). This article demonstrates the important role of poly(ADP-ribose) as an endogenous cofactor of \u03b1-synuclein to regulate its aggregation and pathology in cells.","journal-title":"Science"},{"key":"708_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker, M. & Walker, L. C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45\u201351 (2013).","journal-title":"Nature"},{"key":"708_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00401-010-0761-3","volume":"121","author":"P Gambetti","year":"2011","unstructured":"Gambetti, P. et al. Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta Neuropathol. 121, 79\u201390 (2011).","journal-title":"Acta Neuropathol."},{"key":"708_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/374647a0","volume":"374","author":"L Meda","year":"1995","unstructured":"Meda, L. et al. Activation of microglial cells by \u03b2-amyloid protein and interferon-gamma. Nature 374, 647\u2013650 (1995).","journal-title":"Nature"},{"key":"708_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cell.2010.11.050","volume":"144","author":"H Olzscha","year":"2011","unstructured":"Olzscha, H. et al. Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144, 67\u201378 (2011).","journal-title":"Cell"},{"key":"708_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature21695","volume":"543","author":"L Ruan","year":"2017","unstructured":"Ruan, L. et al. Cytosolic proteostasis through importing of misfolded proteins into mitochondria. Nature 543, 443\u2013446 (2017).","journal-title":"Nature"},{"key":"708_CR20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41586-019-1026-5","volume":"568","author":"B Falcon","year":"2019","unstructured":"Falcon, B. et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 568, 420\u2013423 (2019).","journal-title":"Nature"},{"key":"708_CR21","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng, C. et al. Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies. Nature 557, 558\u2013563 (2018). This article highlights that different cellular environments may lead to the formation of \u03b1-synuclein fibrils with distinct structures and neuropathologies.","journal-title":"Nature"},{"key":"708_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","volume":"561","author":"B Falcon","year":"2018","unstructured":"Falcon, B. et al. Structures of filaments from Pick\u2019s disease reveal a novel tau protein fold. Nature 561, 137\u2013140 (2018).","journal-title":"Nature"},{"key":"708_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature20814","volume":"541","author":"W Qiang","year":"2017","unstructured":"Qiang, W., Yau, W. M., Lu, J. X., Collinge, J. & Tycko, R. Structural variation in amyloid-\u03b2 fibrils from Alzheimer\u2019s disease clinical subtypes. Nature 541, 217\u2013221 (2017).","journal-title":"Nature"},{"key":"708_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick, A. W. P. et al. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease.Nature 547, 185\u2013190 (2017). This paper reports the atomic structure of pathological fibrils directly extracted from the brain of a patient with AD.","journal-title":"Nature"},{"key":"708_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts, W. et al. \u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522, 340\u2013344 (2015). This study highlights the diverse structures and pathologies of different strains of \u03b1-synuclein fibrils.","journal-title":"Nature"},{"key":"708_CR26","doi-asserted-by":"publisher","first-page":"a033878","DOI":"10.1101\/cshperspect.a033878","volume":"12","author":"CM Dobson","year":"2020","unstructured":"Dobson, C. M., Knowles, T. P. J. & Vendruscolo, M. The Amyloid phenomenon and its significance in biology and medicine. Cold Spring Harb. Perspect. Biol. 12, a033878 (2020).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"708_CR27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature03680","volume":"435","author":"R Nelson","year":"2005","unstructured":"Nelson, R. et al. Structure of the cross-\u03b2 spine of amyloid-like fibrils. Nature 435, 773\u2013778 (2005).","journal-title":"Nature"},{"key":"708_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature05695","volume":"447","author":"MR Sawaya","year":"2007","unstructured":"Sawaya, M. R. et al. Atomic structures of amyloid cross-\u03b2 spines reveal varied steric zippers. Nature 447, 453\u2013457 (2007).","journal-title":"Nature"},{"key":"708_CR29","doi-asserted-by":"publisher","first-page":"e43584","DOI":"10.7554\/eLife.43584","volume":"8","author":"W Zhang","year":"2019","unstructured":"Zhang, W. et al. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer\u2019s and Pick\u2019s diseases. eLife 8, e43584 (2019).","journal-title":"eLife"},{"key":"708_CR30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cell.2020.01.027","volume":"180","author":"T Arakhamia","year":"2020","unstructured":"Arakhamia, T. et al. Posttranslational modifications mediate the structural diversity of tauopathy strains. Cell 180, 633\u2013644.e12 (2020). This article highlights the important role of post-translational modifications in determining the structures of Tau fibrils in different types of tauopathies.","journal-title":"Cell"},{"key":"708_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16386-3","volume":"11","author":"K Zhao","year":"2020","unstructured":"Zhao, K. et al. Parkinson\u2019s disease associated mutation E46K of \u03b1-synuclein triggers the formation of a distinct fibril structure. Nat. Commun. 11, 2643 (2020).","journal-title":"Nat. Commun."},{"key":"708_CR32","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1016\/j.jmb.2019.07.001","volume":"431","author":"X Ni","year":"2019","unstructured":"Ni, X., McGlinchey, R. P., Jiang, J. & Lee, J. C. Structural Insights into \u03b1-synuclein fibril polymorphism: effects of Parkinson\u2019s disease-related C-terminal truncations. J. Mol. Biol. 431, 3913\u20133919 (2019).","journal-title":"J. Mol. Biol."},{"key":"708_CR33","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","volume":"28","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Amyloid fibril structure of \u03b1-synuclein determined by cryo-electron microscopy. Cell Res. 28, 897\u2013903 (2018).","journal-title":"Cell Res."},{"key":"708_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05971-2","volume":"9","author":"B Li","year":"2018","unstructured":"Li, B. et al. Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel. Nat. Commun. 9, 3609 (2018).","journal-title":"Nat. Commun."},{"key":"708_CR35","doi-asserted-by":"publisher","first-page":"e36402","DOI":"10.7554\/eLife.36402","volume":"7","author":"R Guerrero-Ferreira","year":"2018","unstructured":"Guerrero-Ferreira, R. et al. Cryo-EM structure of \u03b1-synuclein fibrils. eLife 7, e36402 (2018).","journal-title":"eLife"},{"key":"708_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12683-8","volume":"10","author":"M Kollmer","year":"2019","unstructured":"Kollmer, M. et al. Cryo-EM structure and polymorphism of A\u03b2 amyloid fibrils purified from Alzheimer\u2019s brain tissue. Nat. Commun. 10, 4760 (2019).","journal-title":"Nat. Commun."},{"key":"708_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1126\/science.aao2825","volume":"358","author":"L Gremer","year":"2017","unstructured":"Gremer, L. et al. Fibril structure of amyloid-\u03b2(1-42) by cryo-electron microscopy. Science 358, 116\u2013119 (2017).","journal-title":"Science"},{"key":"708_CR38","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41594-020-0441-5","volume":"27","author":"LQ Wang","year":"2020","unstructured":"Wang, L. Q. et al. Cryo-EM structure of an amyloid fibril formed by full-length human prion protein. Nat. Struct. Mol. Biol. 27, 598\u2013602 (2020). This study shows non-proteinaceous molecules that mediate the formation of fibrils of full-length human prions.","journal-title":"Nat. Struct. Mol. Biol."},{"key":"708_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41594-020-0403-y","volume":"27","author":"C Glynn","year":"2020","unstructured":"Glynn, C. et al. Cryo-EM structure of a human prion fibril with a hydrophobic, protease-resistant core. Nat. Struct. Mol. Biol. 27, 417\u2013423 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"708_CR40","doi-asserted-by":"publisher","first-page":"20305","DOI":"10.1073\/pnas.1922741117","volume":"117","author":"K Zhao","year":"2020","unstructured":"Zhao, K. et al. Parkinson\u2019s disease-related phosphorylation at Tyr39 rearranges \u03b1-synuclein amyloid fibril structure revealed by cryo-EM. Proc. Natl. Acad. Sci. USA 117, 20305\u201320315 (2020). This study reveals the structural basis of how a disease-associated phosphorylation induces the formation of a new fibril structure of \u03b1-synuclein with enhanced stability and neurotoxicity.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"708_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/BF01945246","volume":"16","author":"N Friedrich","year":"1859","unstructured":"Friedrich, N. & Kekule, A. Zur amyloidfrage. Virchows Arch. Pathol. Anat. Physiol. 16, 50\u201365 (1859).","journal-title":"Virchows Arch. Pathol. Anat. Physiol."},{"key":"708_CR42","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1021\/acs.biochem.9b01069","volume":"59","author":"D Li","year":"2020","unstructured":"Li, D. & Liu, C. Structural diversity of amyloid fibrils and advances in their structure determination. Biochemistry 59, 639\u2013646 (2020).","journal-title":"Biochemistry"},{"key":"708_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.sbi.2019.05.003","volume":"58","author":"AW Fitzpatrick","year":"2019","unstructured":"Fitzpatrick, A. W. & Saibil, H. R. Cryo-EM of amyloid fibrils and cellular aggregates. Curr. Opin. Struct. Biol. 58, 34\u201342 (2019).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"708_CR44","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","volume":"19","author":"MG Iadanza","year":"2018","unstructured":"Iadanza, M. G., Jackson, M. P., Hewitt, E. W., Ranson, N. A. & Radford, S. E. A new era for understanding amyloid structures and disease. Nat. Rev. Mol. Cell Biol. 19, 755\u2013773 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"708_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.conb.2020.01.014","volume":"61","author":"R Guerrero-Ferreira","year":"2020","unstructured":"Guerrero-Ferreira, R., Kovacik, L., Ni, D. & Stahlberg, H. New insights on the structure of \u03b1-synuclein fibrils using cryo-electron microscopy. Curr. Opin. Neurobiol. 61, 89\u201395 (2020).","journal-title":"Curr. Opin. Neurobiol."},{"key":"708_CR46","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1101\/sqb.2018.83.037580","volume":"83","author":"M Goedert","year":"2018","unstructured":"Goedert, M., Falcon, B., Zhang, W., Ghetti, B. & Scheres, S. H. W. Distinct conformers of assembled tau in Alzheimer\u2019s and Pick\u2019s diseases. Cold Spring Harb. Symp. Quant. Biol. 83, 163\u2013171 (2018).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"708_CR47","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1126\/science.6801762","volume":"216","author":"SB Prusiner","year":"1982","unstructured":"Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136\u2013144 (1982).","journal-title":"Science"},{"key":"708_CR48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev-genet-120215-034943","volume":"50","author":"LC Walker","year":"2016","unstructured":"Walker, L. C. Proteopathic strains and the heterogeneity of neurodegenerative diseases. Annu. Rev. Genet. 50, 329\u2013346 (2016).","journal-title":"Annu. Rev. Genet."},{"key":"708_CR49","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neuron.2016.01.026","volume":"89","author":"DW Sanders","year":"2016","unstructured":"Sanders, D. W., Kaufman, S. K., Holmes, B. B. & Diamond, M. I. Prions and protein assemblies that convey biological information in health and disease. Neuron 89, 433\u2013448 (2016).","journal-title":"Neuron"},{"key":"708_CR50","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/2654","volume":"4","author":"J Safar","year":"1998","unstructured":"Safar, J. et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4, 1157\u20131165 (1998).","journal-title":"Nat. Med."},{"key":"708_CR51","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1138718","volume":"318","author":"J Collinge","year":"2007","unstructured":"Collinge, J. & Clarke, A. R. A general model of prion strains and their pathogenicity. Science 318, 930\u2013936 (2007).","journal-title":"Science"},{"key":"708_CR52","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1146\/annurev-genet-110711-155524","volume":"47","author":"SB Prusiner","year":"2013","unstructured":"Prusiner, S. B. Biology and genetics of prions causing neurodegeneration. Annu. Rev. Genet. 47, 601\u2013623 (2013).","journal-title":"Annu. Rev. Genet."},{"key":"708_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-071714-033828","volume":"38","author":"LC Walker","year":"2015","unstructured":"Walker, L. C. & Jucker, M. Neurodegenerative diseases: expanding the prion concept. Annu. Rev. Neurosci. 38, 87\u2013103 (2015).","journal-title":"Annu. Rev. Neurosci."},{"key":"708_CR54","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","volume":"82","author":"DW Sanders","year":"2014","unstructured":"Sanders, D. W. et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82, 1271\u20131288 (2014).","journal-title":"Neuron"},{"key":"708_CR55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-015-1503-3","volume":"131","author":"S Taniguchi-Watanabe","year":"2016","unstructured":"Taniguchi-Watanabe, S. et al. Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau. Acta Neuropathol. 131, 267\u2013280 (2016).","journal-title":"Acta Neuropathol."},{"key":"708_CR56","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-014-1373-0","volume":"129","author":"S Boluda","year":"2015","unstructured":"Boluda, S. et al. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer\u2019s disease or corticobasal degeneration brains. Acta Neuropathol. 129, 221\u2013237 (2015).","journal-title":"Acta Neuropathol."},{"key":"708_CR57","doi-asserted-by":"publisher","first-page":"9679","DOI":"10.1073\/pnas.0812083106","volume":"106","author":"Y Nekooki-Machida","year":"2009","unstructured":"Nekooki-Machida, Y. et al. Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc. Natl. Acad. Sci. USA 106, 9679\u20139684 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"708_CR58","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1002\/cne.23430","volume":"521","author":"SE Arnold","year":"2013","unstructured":"Arnold, S. E. et al. Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases. J. Comp. Neurol. 521, 4339\u20134355 (2013).","journal-title":"J. Comp. Neurol."},{"key":"708_CR59","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/jnen\/nly080","volume":"77","author":"J Brettschneider","year":"2018","unstructured":"Brettschneider, J. et al. Converging patterns of \u03b1-synuclein pathology in multiple system atrophy. J. Neuropathol. Exp. Neurol. 77, 1005\u20131016 (2018).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"708_CR60","doi-asserted-by":"crossref","unstructured":"Trojanowski, J. Q., Revesz, T. & Neuropathology Working Group on MSA. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol. Appl. Neurobiol. 33, 615\u2013620 (2007).","DOI":"10.1111\/j.1365-2990.2007.00907.x"},{"key":"708_CR61","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. \u03b1-synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"708_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13787-x","volume":"11","author":"Z He","year":"2020","unstructured":"He, Z. et al. Transmission of tauopathy strains is independent of their isoform composition. Nat. Commun. 11, 7 (2020).","journal-title":"Nat. Commun."},{"key":"708_CR63","doi-asserted-by":"publisher","first-page":"e48907","DOI":"10.7554\/eLife.48907","volume":"8","author":"R Guerrero-Ferreira","year":"2019","unstructured":"Guerrero-Ferreira, R. et al. Two new polymorphic structures of human full-length \u03b1-synuclein fibrils solved by cryo-electron microscopy. eLife 8, e48907 (2019).","journal-title":"eLife"},{"key":"708_CR64","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","volume":"23","author":"MD Tuttle","year":"2016","unstructured":"Tuttle, M. D. et al. Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein. Nat. Struct. Mol. Biol. 23, 409\u2013415 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"708_CR65","doi-asserted-by":"publisher","first-page":"18349","DOI":"10.1073\/pnas.0806270105","volume":"105","author":"AK Paravastu","year":"2008","unstructured":"Paravastu, A. K., Leapman, R. D., Yau, W. M. & Tycko, R. Molecular structural basis for polymorphism in Alzheimer\u2019s \u03b2-amyloid fibrils. Proc. Natl. Acad. Sci. USA 105, 18349\u201318354 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"708_CR66","doi-asserted-by":"publisher","first-page":"22262","DOI":"10.1074\/jbc.M110.202937","volume":"286","author":"G De Franceschi","year":"2011","unstructured":"De Franceschi, G. et al. Structural and morphological characterization of aggregated species of \u03b1-synuclein induced by docosahexaenoic acid. J. Biol. Chem. 286, 22262\u201322274 (2011).","journal-title":"J. Biol. Chem."},{"key":"708_CR67","doi-asserted-by":"publisher","first-page":"7024","DOI":"10.1021\/bi0002479","volume":"39","author":"T Miura","year":"2000","unstructured":"Miura, T., Suzuki, K., Kohata, N. & Takeuchi, H. Metal binding modes of Alzheimer\u2019s amyloid \u03b2-peptide in insoluble aggregates and soluble complexes. Biochemistry 39, 7024\u20137031 (2000).","journal-title":"Biochemistry"},{"key":"708_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06548-9","volume":"9","author":"S Porta","year":"2018","unstructured":"Porta, S. et al. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat. Commun. 9, 4220 (2018).","journal-title":"Nat. Commun."},{"key":"708_CR69","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","volume":"16","author":"C Peng","year":"2020","unstructured":"Peng, C., Trojanowski, J. Q. & Lee, V. M. Protein transmission in neurodegenerative disease. Nat. Rev. Neurol. 16, 199\u2013212 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"708_CR70","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1110\/ps.073127808","volume":"17","author":"JS Pedersen","year":"2008","unstructured":"Pedersen, J. S. & Otzen, D. E. Amyloid-a state in many guises: survival of the fittest fibril fold. Protein Sci. 17, 2\u201310 (2008).","journal-title":"Protein Sci."},{"key":"708_CR71","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1073\/pnas.1808845116","volume":"116","author":"PM Levine","year":"2019","unstructured":"Levine, P. M. et al. \u03b1-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson\u2019s disease. Proc. Natl. Acad. Sci. USA 116, 1511\u20131519 (2019). This study highlights that GlcNAcylation at different sites of \u03b1-synuclein exhibits distinctive effects on \u03b1-synuclein aggregation and toxicity.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"708_CR72","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1172\/JCI85456","volume":"126","author":"S Brahmachari","year":"2016","unstructured":"Brahmachari, S. et al. Activation of tyrosine kinase c-Abl contributes to \u03b1-synuclein-induced neurodegeneration. J. Clin. Invest. 126, 2970\u20132988 (2016).","journal-title":"J. Clin. Invest."},{"key":"708_CR73","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/nn.4067","volume":"18","author":"M Morris","year":"2015","unstructured":"Morris, M. et al. Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice. Nat. Neurosci. 18, 1183\u20131189 (2015).","journal-title":"Nat. Neurosci."},{"key":"708_CR74","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/hmg\/ddt674","volume":"23","author":"AL Mahul-Mellier","year":"2014","unstructured":"Mahul-Mellier, A. L. et al. c-Abl phosphorylates \u03b1-synuclein and regulates its degradation: implication for \u03b1-synuclein clearance and contribution to the pathogenesis of Parkinson\u2019s disease. Hum. Mol. Genet. 23, 2858\u20132879 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"708_CR75","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnmol.2014.00042","volume":"7","author":"S Tenreiro","year":"2014","unstructured":"Tenreiro, S., Eckermann, K. & Outeiro, T. F. Protein phosphorylation in neurodegeneration: friend or foe? Front. Mol. Neurosci. 7, 42 (2014).","journal-title":"Front. Mol. Neurosci."},{"key":"708_CR76","doi-asserted-by":"publisher","first-page":"11253","DOI":"10.1073\/pnas.1818530116","volume":"116","author":"ZW Hu","year":"2019","unstructured":"Hu, Z. W. et al. Molecular structure of an N-terminal phosphorylated \u03b2-amyloid fibril. Proc. Natl. Acad. Sci. USA 116, 11253\u201311258 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"708_CR77","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1021\/bi011711s","volume":"41","author":"JA Cohlberg","year":"2002","unstructured":"Cohlberg, J. A., Li, J., Uversky, V. N. & Fink, A. L. Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from \u03b1-synuclein in vitro. Biochemistry 41, 1502\u20131511 (2002).","journal-title":"Biochemistry"},{"key":"708_CR78","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1073\/pnas.1601899113","volume":"113","author":"C Galvagnion","year":"2016","unstructured":"Galvagnion, C. et al. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of \u03b1-synuclein. Proc. Natl. Acad. Sci. USA 113, 7065\u20137070 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"708_CR79","first-page":"2181","volume":"150","author":"DM Wilson","year":"1997","unstructured":"Wilson, D. M. & Binder, L. I. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer\u2019s disease. Am. J. Pathol. 150, 2181\u20132195 (1997).","journal-title":"Am. J. Pathol."},{"key":"708_CR80","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S0014-5793(96)01386-5","volume":"399","author":"T Kampers","year":"1996","unstructured":"Kampers, T., Friedhoff, P., Biernat, J., Mandelkow, E. M. & Mandelkow, E. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett. 399, 344\u2013349 (1996).","journal-title":"FEBS Lett."},{"key":"708_CR81","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1021\/acschembio.6b00539","volume":"11","author":"I Dikiy","year":"2016","unstructured":"Dikiy, I. et al. Semisynthetic and in vitro phosphorylation of alpha-synuclein at Y39 promotes functional partly helical membrane-bound states resembling those induced by PD mutations. ACS Chem. Biol. 11, 2428\u20132437 (2016).","journal-title":"ACS Chem. Biol."},{"key":"708_CR82","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature11060","volume":"485","author":"JM Nussbaum","year":"2012","unstructured":"Nussbaum, J. M. et al. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-\u03b2. Nature 485, 651\u2013655 (2012). This study reports that pyroglutamylation of amyloid-\u03b2 plays an important role in mediating its Tau-dependent pathology.","journal-title":"Nature"},{"key":"708_CR83","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.neuron.2011.07.001","volume":"71","author":"MP Kummer","year":"2011","unstructured":"Kummer, M. P. et al. Nitration of tyrosine 10 critically enhances amyloid \u03b2 aggregation and plaque formation. Neuron 71, 833\u2013844 (2011).","journal-title":"Neuron"},{"key":"708_CR84","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/383550a0","volume":"383","author":"M Goedert","year":"1996","unstructured":"Goedert, M. et al. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383, 550\u2013553 (1996).","journal-title":"Nature"},{"key":"708_CR85","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF00309338","volume":"89","author":"K Suzuki","year":"1995","unstructured":"Suzuki, K. et al. Neurofibrillary tangles in Niemann-Pick disease type C. Acta Neuropathol. 89, 227\u2013238 (1995).","journal-title":"Acta Neuropathol."},{"key":"708_CR86","doi-asserted-by":"publisher","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","volume":"2","author":"EM Mandelkow","year":"2012","unstructured":"Mandelkow, E. M. & Mandelkow, E. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb. Perspect. Med. 2, a006247 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"708_CR87","doi-asserted-by":"publisher","first-page":"15277","DOI":"10.1074\/jbc.M117.794602","volume":"292","author":"Y Carlomagno","year":"2017","unstructured":"Carlomagno, Y. et al. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function. J. Biol. Chem. 292, 15277\u201315286 (2017).","journal-title":"J. Biol. Chem."},{"key":"708_CR88","doi-asserted-by":"publisher","unstructured":"Seidler, P. et al. CryoEM reveals how the small molecule EGCG binds to Alzheimer\u2019s brain-derived tau fibrils and initiates fibril disaggregation. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2020.05.29.124537 (2020).","DOI":"10.1101\/2020.05.29.124537"},{"key":"708_CR89","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1126\/science.abb2491","volume":"368","author":"N Hartrampf","year":"2020","unstructured":"Hartrampf, N. et al. Synthesis of proteins by automated flow chemistry. Science 368, 980\u2013987 (2020).","journal-title":"Science"}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-020-00708-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-020-00708-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-020-00708-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T23:30:37Z","timestamp":1674775837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-020-00708-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1038\/s41589-020-00708-z","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"13 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}